Search result for 'Lupin Ltd.'

Lupin Appoints CEO for New Manufacturing Arm

June 17, 2024 12:52

Lupin Ltd appoints Abdelaziz Toumi as CEO of its newly formed subsidiary, Lupin Manufacturing Solutions, a CDMO focused on API development and manufacturing.

Lupin Appoints Jeffrey Kindler, Alfonso Zulueta as Independent Directors

May 9, 2024 12:44

Lupin Ltd. has appointed Jeffrey Kindler, former Pfizer CEO, and Alfonso 'Chito' Zulueta as independent directors on its board. Both bring extensive experience in healthcare and pharmaceutical...

Lupin Gets USFDA Approval for Pregnancy Prevention Drug

February 16, 2024 14:02

Lupin Ltd. receives USFDA approval to market its generic 'Minzoya' tablets for pregnancy prevention. The drug is a generic equivalent of Balcoltra, with estimated annual sales of USD 42 million in...

Lupin Launches Ganirelix Acetate Injection in US - Fertility Treatment

February 15, 2024 14:06

Lupin launches Ganirelix Acetate injection in the US, a generic for fertility treatments, approved by the USFDA. The injection inhibits premature LH surges during controlled ovarian hyperstimulation.

Lupin Q3 Profit Soars 4x to Rs 613 Cr - Strong Sales Growth

February 7, 2024 22:18

Lupin's net profit for Q3 FY24 jumped four-fold to Rs 613 crore, driven by robust sales growth across geographies. Revenue from operations also saw a significant rise.

Lupin Gets USFDA Approval for Generic Hyperuricemia Drug

January 18, 2024 17:37

Lupin receives USFDA approval to market generic Febuxostat tablets for the treatment of hyperuricemia in adults with gout. The drug, a generic equivalent of Uloric, will be manufactured in India.

Lupin Gets USFDA Approval for Generic Hypertension Drug

January 14, 2024 16:14

Lupin receives USFDA approval to market generic hypertension drug Propranolol Hydrochloride extended-release capsules in the US, a generic version of ANI Pharmaceuticals' Inderal LA.

Lupin Gets USFDA Approval for Generic Loteprednol Etabonate

December 27, 2023 16:35

Lupin has received USFDA approval for its generic Loteprednol Etabonate ophthalmic suspension, a treatment for seasonal allergic conjunctivitis. The product is a generic equivalent to Alrex...

Lupin Acquires Products from Sanofi for Rs 91 Crore

December 22, 2023 13:29

Lupin Ltd has acquired established products in Europe and Canada from Sanofi for Rs 91 crore. The acquisition includes brands like AARANE and NALCROM and is expected to be completed by the first...

Lupin Diagnostics Opens New Regional Reference Lab in Chennai

December 14, 2023 20:06

Lupin Diagnostics inaugurates a state-of-the-art Regional Reference Laboratory in Chennai, expanding its network to 36 labs and 600 collection centers across India.

Air India Copenhagen-Delhi Flight Cancelled:...

Air India cancels Copenhagen-Delhi flight on June 30 due to technical and operational...

TCS Sponsors Sydney Marathon: 5-Year Deal

TCS becomes title sponsor of the Sydney Marathon for 5 years, adding to its global...

Emcure Pharma IPO: Rs 583 Cr Raised from Anchor...

Emcure Pharmaceuticals, backed by Bain Capital, has raised Rs 583 crore from anchor...

Moneywiz Live!

ALL MONEYWIZ PAGES

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us